Sirona Biochem (CVE:SBM) Shares Down 16.7% – What’s Next?

Sirona Biochem Corp. (CVE:SBM)’s share price fell 16.7% on Tuesday . The stock traded as low as C$0.05 and last traded at C$0.05. 113,000 shares traded hands during trading, an increase of 91% from the average session volume of 59,069 shares. The stock had previously closed at C$0.06.

Sirona Biochem Price Performance

The stock has a market cap of C$12.84 million, a PE ratio of -5.00 and a beta of -0.03. The business has a fifty day simple moving average of C$0.06 and a two-hundred day simple moving average of C$0.06. The company has a current ratio of 0.34, a quick ratio of 2.41 and a debt-to-equity ratio of 219.21.

About Sirona Biochem

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.